Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARHEEL: Switching from Stavudine in HIV
NCT00005764Phase 4Completed
- Sponsor
- GSK
- Start
- May 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of abacavir, lamivudine + zidovudine in human immunodeficiency virus infection (HIV), sponsored by GSK. Started May 2000; status: completed.
02
Drugs
abacavirlamivudine + zidovudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00005764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005764.